Blastic Plasmacytoid Dendritic Cell Neoplasm Bpdcn clinical trials

Explore recruiting blastic plasmacytoid dendritic cell neoplasm bpdcn clinical trials.

Recruiting blastic plasmacytoid dendritic cell neoplasm bpdcn studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Blastic Plasmacytoid Dendritic Cell Neoplasm Bpdcn trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An open-label, first-in-human, dose-escalation/expansion study of SAR443579 administered as single agent by intravenous infusion in adult and pediatric participants with relapsed or refractory acute myeloid leukemia (R/R AML), B-cell acute lymphoblastic leukemia (B-ALL), high risk-myelodysplasia (HR-MDS), or blastic plasmacytoid dendritic cell neoplasm (BPDCN)

France, Netherlands

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Blastic Plasmacytoid Dendritic Cell Neoplasm Bpdcn trials by city

Blastic Plasmacytoid Dendritic Cell Neoplasm Bpdcn in Toronto Blastic Plasmacytoid Dendritic Cell Neoplasm Bpdcn in Vancouver Blastic Plasmacytoid Dendritic Cell Neoplasm Bpdcn in Montreal Blastic Plasmacytoid Dendritic Cell Neoplasm Bpdcn in Calgary Blastic Plasmacytoid Dendritic Cell Neoplasm Bpdcn in Edmonton Blastic Plasmacytoid Dendritic Cell Neoplasm Bpdcn in Ottawa Blastic Plasmacytoid Dendritic Cell Neoplasm Bpdcn in Winnipeg Blastic Plasmacytoid Dendritic Cell Neoplasm Bpdcn in Quebec City Blastic Plasmacytoid Dendritic Cell Neoplasm Bpdcn in Hamilton Blastic Plasmacytoid Dendritic Cell Neoplasm Bpdcn in Kitchener Blastic Plasmacytoid Dendritic Cell Neoplasm Bpdcn in London Blastic Plasmacytoid Dendritic Cell Neoplasm Bpdcn in Halifax Blastic Plasmacytoid Dendritic Cell Neoplasm Bpdcn in New York Blastic Plasmacytoid Dendritic Cell Neoplasm Bpdcn in Los Angeles Blastic Plasmacytoid Dendritic Cell Neoplasm Bpdcn in Chicago Blastic Plasmacytoid Dendritic Cell Neoplasm Bpdcn in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease